advertisement

---

Tomita G 8

Showing records 1 to 8 | Display all abstracts from Tomita G

90701 One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study
Tsukahara S
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 512-521

---

90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Higashide T
Ophthalmology. Glaucoma 2020; 0:

---

90701 One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study
Enomoto N
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 512-521

---

90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Ohkubo S; Udagawa S
Ophthalmology. Glaucoma 2020; 0:

---

90701 One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study
Ishida K
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 512-521

---

90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Sugiyama K
Ophthalmology. Glaucoma 2020; 0:

---

90701 One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study
Anraku A; Tomita G
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 512-521

---

90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Tanihara H; Araie M; Tomita G; Matsumoto C; Fukuchi T; Tomidokoro A; Hangai M; Kawata H; Inai M; Tanaka Y;
Ophthalmology. Glaucoma 2020; 0:

---